143697-02-3

Basic information

• Product Name: 4(1H)-Pyridinone, 2-ethyl-3-(phenylmethoxy)-
• CAS NO: 143697-02-3
• Molecular Formula: C14H15NO2
• Molecular Weight: 229.279
• Mol File: 143697-02-3.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 4(1H)-Pyridinone, 2-ethyl-3-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4(1H)-Pyridinone, 2-ethyl-3-(phenylmethoxy)-(143697-02-3)
• EPA Substance Registry System: 4(1H)-Pyridinone, 2-ethyl-3-(phenylmethoxy)-(143697-02-3)

Safety Data

• Hazardous Substances Data: 143697-02-3(Hazardous Substances Data)

Upstream product

• 100-39-0 benzyl bromide 
• 100-44-7 benzyl chloride 
• 4940-11-8 2-ethyl-3-hydroxy-4-pyranone 
• 111782-87-7 3-(benzyloxy)-2-ethyl-4H-pyran-4-one 

Downstream Products

• 349141-24-8 2-(1'-acetoxyethyl)-3,4-dibenzyloxypyridine 
• 349141-18-0 2-ethyl-3,4-dibenzyloxypyridine N-oxide 
• 349141-19-1 2-(1'-hydroxyethyl)-3,4-dibenzyloxypyridine 
• 349141-17-9 2-ethyl-3,4-dibenzyloxypyridine 
• 1026096-79-6 3-Benzyloxy-2-ethyl-1-trimethylsilanyl-1H-pyridin-4-one 
• 178627-02-6 3-Benzyloxy-1-(2-benzyloxy-ethoxymethyl)-2-ethyl-1H-pyridin-4-one 

Relevant articles and documents

Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer's disease

A series of hybrids of hydroxypyridinone and coumarin were rationally designed, synthesized and biologically evaluated for their iron ion chelating and MAO-B inhibitory activities. Most of the compounds displayed excellent iron ion chelating effects and moderate to good anti-MAO-B activities. Compound 27a exhibited the most potent activity against MAO-B, with an IC50 value of 14.7 nM. Importantly, 27a showed good U251 cell protective effect and significantly ameliorated the cognitive dysfunction of scopolamine-induced AD mice. Moreover, molecular docking was performed to elucidate the probable ligand-receptor interaction, and the structure-activity relationships were also summarized.

Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives

A series of Mannich bases of 2-alkyl-3-hydroxy-pyridine-4-ones, namely 2-alkyl-3-hydroxy-5-N-piperidylmethyl or N,N-dialkylaminomethyl pyridine-4-ones 9, 10 and 15-18, two derivatives of N-aryl-2-methyl-3-hydroxy-pyridine-4-ones 19, 20 and two N-alkyl derivatives of maltol, 21 and 22 were prepared. They were screened for their antibacterial and antifungal activities against a variety of microorganisms using micro plate Alamar Blue assay (MABA) method. Multiple linear regressions (MLR) analysis was performed for the synthesized compounds as well as a series of pyridinone and pyranone derivatives 23-43 which have been synthesized and evaluated for antimicrobial activity by other researchers previously. Studied compounds showed a better quantitative structure-activity relationship (QSAR) model for the antimicrobial activity against Candida albicans and Staphylococcus aureus in comparison with other tested microorganisms.

Synthesis, physicochemical properties, and biological evaluation of N- substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: Orally active iron chelators with clinical potential

The synthesis of a range of novel bidentate ligands containing the chelating moiety 3-hydroxy-4(1H)-pyridinone is described. The pK(a) values of the ligands and the stability constants of their iron(III) complexes have been determined. The crystal structures of one of the ligands and one of the iron(III) complexes are presented. The distribution coefficients of the ligands are reported and are related to the ability of the ligands to remove iron from hepatocytes. The influence of 3-hydroxy-4(1H)-pyridinones on oxidative damage to cells is described. In contrast to the iron chelator in current therapeutic use, desferrioxamine-B, many of the bidentate ligands described in this study are orally active in iron-overloaded mice.